Walleye Capital LLC United Therapeutics Corp Call Options Transaction History

Walleye Capital LLC

12 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 14, 2024	BUY	$311.04 - $363.55 $1.31 Million - $1.53 Million	4,200 Added 840.0%	4,700 $1.68 Million
Q2 2024 Aug 14, 2024	SELL	$228.26 - $319.04 $296,738 - $414,752	-1,300 Reduced 72.22%	500 $159,000
Q1 2024 May 15, 2024	SELL	$210.76 - $249.51 $147,532 - $174,657	-700 Reduced 28.0%	1,800 $413,000
Q4 2023 Feb 14, 2024	BUY	$214.88 - $256.94 $257,856 - $308,328	1,200 Added 92.31%	2,500 $549,000
Q3 2023 Nov 14, 2023	BUY	$211.82 - $248.24 $148,274 - $173,768	700 Added 116.67%	1,300 $293,000
Q2 2023 Aug 14, 2023	BUY	$205.19 - $232.99 $123,114 - $139,794	600 New	600 $132,000
Q4 2022 Feb 14, 2023	BUY	$205.95 - $280.43 $82,380 - $112,172	400 New	400 $111,000
Q1 2020 May 15, 2020	SELL	$79.39 - $115.35 $1.41 Million - $2.04 Million	-17,700 Closed	0 $0
Q4 2019 Feb 14, 2020	SELL	$78.31 - $95.34 $180,113 - $219,282	-2,300 Reduced 11.5%	17,700 $1.56 Million
Q3 2019 Nov 14, 2019	SELL	$74.85 - $85.99 $67,365 - $77,391	-900 Reduced 4.31%	20,000 $1.6 Million
Q2 2019 Aug 14, 2019	BUY	$76.06 - $120.81 $1.32 Million - $2.09 Million	17,300 Added 480.56%	20,900 $1.63 Million
Q1 2019 May 15, 2019	BUY	$107.15 - $126.84 $385,740 - $456,624	3,600 New	3,600 $423,000

671

42.3M

194K

295K

Ticker UTHR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,516,300
Market Cap $16.4B
Description
United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...

Get notified when there are updates to the investment portfolio of Walleye Capital LLC, based on Form 13F filings with the SEC.

Stay updated on Walleye Capital LLC with notifications on news.